CXCR 3 deficiency enhances tumor progression by promoting macrophage M2 polarization in a murine breast cancer model
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Summary: Tumor associated macrophages play a vital role in determining the outcome of breast cancer. We investigated the contribution of the chemokine receptor CXCR 3 to antitumor immune responses using a cxcr3 deficient mouse orthotopically injected with a Py MT breast cancer cell line. We observed that cxcr3 deficient mice displayed increased IL‐4 production and M2 polarization in the tumors and spleens compared to WT mice injected with Py MT cells. This was accompanied by larger tumor development in cxcr3−/− than in WT mice. Further, tumor‐promoting myeloid derived immune cell populations accumulated in higher proportions in the spleens of cxcr3 deficient mice. Interestingly, cxcr3−/− macrophages displayed a deficiency in up‐regulating inducible nitric oxide synthase after stimulation by either IFN‐γ or Py MT supernatants. Stimulation of bone marrow derived macrophages by Py MT supernatants also resulted in greater induction of arginase‐1 in cxcr3−/− than WT mice. Further, cxcr3−/− T cells activated with CD 3/CD 28 in vitro produced greater amounts of IL‐4 and IL‐10 than T cells from WT mice. Our data suggests that a greater predisposition of cxcr3 deficient macrophages towards M2 polarization contributes to an enhanced tumor promoting environment in cxcr3 deficient mice. Although CXCR 3 is known to be expressed on some macrophages, this is the first report that demonstrates a role for CXCR 3 in macrophage polarization and subsequent breast tumor outcomes. Targeting CXCR 3 could be a potential therapeutic approach in the management of breast cancer tumors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Doedens, A. L., Stockmann, C., Rubinstein, M. P., Liao, D., Zhang, N., DeNardo, D. G., Coussens, L. M., Karin, M., Goldrath, A. W., & Johnson, R. S. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1439 · Cited by 652
T-bet is required for optimal proinflammatory CD4+ T-cell trafficking
Lord, G. M. (2005) · Blood · doi:10.1182/blood-2005-04-1393 · Cited by 270
Cited by
CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation - a target for novel cancer therapy
Tokunaga, R., Zhang, W., Naseem, M., Puccini, A., Berger, M. D., Soni, S., McSkane, M., Baba, H., & Lenz, H.-J. (2018) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2017.11.007 · Cited by 1,627
“Interestingly, Oghumu et al clarified that CXCR3 deficient mice displayed increased IL-4 production and M2 polarization in a murine breast cancer model, and decreased innate and immune cell-mediated anti-tumor responses.[47] However, on the contrary, Liu et al.”
BackgroundMikucki, M. E., Fisher, D. T., Matsuzaki, J., Skitzki, J. J., Gaulin, N. B., Muhitch, J. B., Ku, A. W., Frelinger, J. G., Odunsi, K., Gajewski, T. F., et al. (2015) · Nature Communications · doi:10.1038/ncomms8458 · Cited by 512
Chow, M. T., & Luster, A. D. (2014) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-14-0160 · Cited by 485
Fu, X.-L., Duan, W., Su, C.-Y., Mao, F.-Y., Lv, Y.-P., Teng, Y.-S., Yu, P.-W., Zhuang, Y., & Zhao, Y.-L. (2017) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-017-2052-5 · Cited by 242
Kauder, S. E., Kuo, T. C., Harrabi, O., Chen, A., Sangalang, E., Doyle, L., Rocha, S. S., Bollini, S., Han, B., Sim, J., et al. (2018) · PLOS ONE · doi:10.1371/journal.pone.0201832 · Cited by 168
Metadata
- Authors
- Oghumu, S., Varikuti, S., Terrazas, C., Kotov, D., Nasser, M. W., Powell, C. A., Ganju, R. K., & Satoskar, A. R.
- Venue
- Immunology
- Publisher
- Wiley
- Published
- 2014-07-29
- Volume
- 143
- Issue
- 1
- Pages
- 109-119
- ISSN
- 0019-2805 (ISSN-L)
- 1365-2567
- OpenAlex
- W1969498205
- Cited by
- 84
- References
- 2
- FWCI
- 2.98
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: CXCR 3 deficiency enhances tumor progression by promoting macrophage M2 polarization in a murine breast cancer model. https://app.cochat.ai/papers/10.1111/imm.12293
- The paper
- Oghumu, S., Varikuti, S., Terrazas, C., Kotov, D., Nasser, M. W., Powell, C. A., Ganju, R. K., & Satoskar, A. R. (2014). CXCR 3 deficiency enhances tumor progression by promoting macrophage M2 polarization in a murine breast cancer model. Immunology. https://doi.org/10.1111/imm.12293
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.